Comparison 14. Triphasic NGM 180‐215‐250 μg and EE 35 μg versus monophasic NETA 1000 μg and EE 20 μg.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Pregnancy per woman within 6 cycles | 1 | 373 | Odds Ratio (M‐H, Random, 95% CI) | 0.99 [0.14, 7.14] |
2 Proportion of women with spotting or breakthrough bleeding at cycle 6 | 1 | 231 | Odds Ratio (M‐H, Random, 95% CI) | 0.26 [0.14, 0.51] |
3 Proportion of women with amenorrhea at cycle 6 | 1 | 231 | Odds Ratio (M‐H, Random, 95% CI) | 0.17 [0.06, 0.45] |
4 Total discontinuation within 6 cycles | 1 | 373 | Odds Ratio (M‐H, Random, 95% CI) | 1.04 [0.68, 1.58] |
5 Discontinuation due to adverse events within 6 cycles | 1 | 373 | Odds Ratio (M‐H, Random, 95% CI) | 0.99 [0.50, 1.98] |